Proportion of isolates with decreased susceptibility or resistance in Latvia
Latvia: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile
Proportion of isolates with decreased susceptibility or resistance in Latvia, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with decreased susceptibility or resistance in Latvia is 0, measured in 2018. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 100.0% over five years.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Latvia peaked at 2.63 in 2013 and was at its lowest, 0, in 2009.
That places Latvia 25th out of 51 countries with data for 2018, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in Latvia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 0 | — |
| 2011 | 0 | — |
| 2012 | 2.56 | — |
| 2013 | 2.63 | +2.6% |
| 2014 | 0 | -100.0% |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 0.5773 | 0 | 2.63 | 9 |
Countries ranked near Latvia
- 22 New Zealand 0.4386 compare
- 23 United States of America 0.2907 compare
- 24 Australia 0.0666 compare
- 25 Cuba 0
- 25 Norway 0 compare
- 25 Slovakia 0 compare
- 25 France 0 compare
- 25 Colombia 0
- 25 Paraguay 0
- 25 Malta 0 compare
- 25 South Africa 0
- 25 Netherlands 0 compare
- 25 Slovenia 0 compare
- 25 Argentina 0 compare
- 25 Côte d'Ivoire 0
- 25 Russian Federation 0
- 25 Bhutan 0 compare
- 25 Portugal 0 compare
- 25 Estonia 0
- 25 Dominican Republic 0
- 25 Pakistan 0 compare
- 25 Peru 0 compare
- 25 Chile 0
- 25 Iceland 0
- 25 Denmark 0 compare
- 25 Panama 0
- 25 Ireland 0 compare
- 25 Sri Lanka 0
- 25 Korea 0 compare
More health data for Latvia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.3876 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,593 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.17 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0202 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.02 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Latvia?
- Proportion of isolates with decreased susceptibility or resistance in Latvia was 0 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Latvia?
- The highest recorded value was 2.63 in 2013.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Latvia?
- The lowest recorded value was 0 in 2009.
- How does Latvia rank for proportion of isolates with decreased susceptibility or resistance?
- Latvia ranks 25th out of 51 countries with data for 2018.
- Where does this Latvia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).